Aggrecan is degraded by matrix metalloproteinases in human arthritis: Evidence that matrix metalloproteinase and aggrecanase activities can be independent

Journal of Clinical Investigation

Volumn 98, Issue 10, 1996, Pages 2292-2299

  Fosang, Amanda J ^a   Last, Karena ^a   Maciewicz, Rose A ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ASTRAZENECA   (United Kingdom)

Author keywords

arthritides; collagenase; proteinase; proteoglycan; synovial fluid

Indexed keywords

AGGRECAN; CHONDROITIN SULFATE; METALLOPROTEINASE;

ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYNOVIAL FLUID;

EID: 0029852094     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119040     Document Type: Article

References (63)

1. Heinegård, D., S. Inerot, J. Wieslander, and G. Lindblad. 1985. A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease. Scand. J. Clin. Lab. Invest. 45:421-427.
2. Saxne, T., D. Heinegård, F.A. Wollheim, and H. Pettersson. 1985. Differences in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet. 20:127-128.
3. Witter, J., P.J. Roughley, C. Webber, N. Roberts, E. Keystone, and A.R. Poole. 1987. The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum. 30:519-529.
4. Saxne, T., D. Heinegård, and F.A. Wollheim. 1986. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann. Rheum. Dis. 45:491-497.
5. Saxne, T., and D. Heinegård. 1992. Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions. Arthritis Rheum. 35:385-390.
6. Saxne, T., F. Castro, U. Rydholm, and H. Svantesson. 1989. Cartilage derived proteoglycans in body fluids of children. Inverse correlation with age. J. Rheumatol. 16:1341-1344.
7. Poole, A.R., M. Ionescu, A. Swan, and P.A. Dieppe. 1994. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. J. Clin. Invest. 94:25-33.
8. Carroll, G. 1989. Measurement of sulfated glycosaminoglycans and proteoglycan fragments in arthritic synovial fluid. Ann. Rheum. Dis. 48:17-24.
9. Shimozuru, Y., M. Shinmei, T. Naraki, Y. Iwasaki, M.E. Lenz, and E.J.-M.A. Thonar. 1995. Rapid and sensitive sandwich enzyme immunoassay for the quantification of antigenic keratan sulfate in body fluids. Trans. Orthop. Res. Soc. 20:419.
10. Thonar, E.J.-M.A., M.E. Lenz, G.K. Klintworth, B. Caterson, L.M. Pachman, P. Glickman, R. Katz, J. Huff, and K.E. Kuettner. 1985. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum. 28:1367-1376.
11. Ratcliffe, A., W. Shurety, and B. Caterson. 1993. The quantitation of a native chondroitin sulfate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy. Arthritis Rheum 36:543-551.
12. Carlson, C.S., R.F. Loeser, B. Johnslone, H.M. Tulli, D.B. Dobson, and B. Caterson. 1995. Osteoarthritis in cynomolgus macaques. II Detection of modulated proteoglycan epitopes in cartilage and synovial fluid. J. Orthop. Res. 13:399-409.
13. Ratcliffe, A., M. Doherty, R.N. Maini, and T.E. Hardingham. 1988. Increased levels of proteoglycan components in the synovial fluids of patients with acute joint disease. Ann. Rheum. Dis. 47:826-832.
14. Malik, S.C., J.P. Pearson, and C.W. Dick. 1984. A comparison of glycosaminoglycan content of human synovial fluid in different disease stales. Biochem. Soc. Trans. 12:874.
15. Sandy, J.D., C.R. Flannery, P.J. Neame, and L.S. Lohmander. 1992. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J. Clin. Invest. 89:1512-1516.
16. Lohmander, L.S., P.J. Neame, and J.D. Sandy. 1993. The structure of aggrecan fragments in human synovial fluid: evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 36:1214-1222.
17. Lewthwaite, J., S.M. Blake, T.E. Hardingham, P.J. Warden, and B. Henderson. 1994. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit. J. Rheumatol. 21:467-472.
18. Arner, E.C. 1994. Effect of animal age and chronicity of interleukin-1 exposure on cartilage proteoglycan depletion in vivo. J. Orthop. Res. 12:321-330.
19. Cawston, T. 1993. Blocking cartilage destruction with metalloproteinase inhibitors: a valid therapeutic target. Ann. Rheum. Dis. 52:769-770.
20. Mort, J.S., G.R. Dodge, P.J. Roughley, J. Liu, S.J. Finch, G. DiPasquale, and A.R. Poole. 1993. Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix. 13:95-102.
21. Buttle, D.J., C.J. Handley, M.Z. Ilic, J. Saklatvala, M. Murata, and A.J. Barrett. 1993. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases: evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum. 36:1709-1717.
22. Seed, M.P., S. Ismaiel, C.Y. Cheung, T.A. Thomson, C.R. Gardner, R.M. Atkins, and C.J. Elson. 1993. Inhibition of interleukin 1beta induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U27391. Ann. Rheum. Dis. 52:37-43.
23. Hughes, C., B. Caterson, R.J. White, P.J. Roughley, and J.S. Mort. 1992. Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. J. Biol. Chem. 267:16011-16014.
24. Hughes, C.E., B. Caterson, A.J. Fosang, P.J. Roughley, and J.S. Mort. 1995. Monoclonal antibodies that specifically recognise neoepitope sequences generated by "aggrecanase" and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem. J. 305:799-804.
25. Lark, M.W., H. Williams, L.A. Hoerrner, J. Weidner, J.M. Ayala, C.F. Harper, A. Christen, J. Olszewski, Z. Konteatis, R. Webber et al. 1995. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum. Biochem. J. 307:245-252.
26. Fosang, A.J., K. Last, P. Gardiner, D.C. Jackson, and L. Brown. 1995. Development of a cleavage site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids. Biochem. J. 310:337-343.
27. Singer, I.I., D.W. Kawka, E.K. Bayne, S.A. Donatelli, J.R. Weidner, H.R. Williams, J.M. Ayala, R.A. Mumford, M.W. Lark, T.T. Giant, et al. 1995. A metalloproteinase-generated neoepitope is induced and immunolocalizes in articular cartilage during inflammatory arthritis. J. Clin. Invest. 95:2178-2186.
28. Fosang, A.J., P.J. Neame, T.E. Hardingham, G. Murphy, and J.A. Hamilton. 1991. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J. Biol. Chem. 266:15579-15582.
29. Fosang, A.J., P.J. Neame, K. Last, T.E. Hardingham, G. Murphy, and J.A. Hamilton. 1992. The interglobular domain of cartilage aggrecan is cleaved by Pump, gelatinases and cathepsin B. J. Biol. Chem. 267:19470-19474.
30. Fosang, A.J., K. Last, V. Knauper, P.J. Neame, G. Murphy, T.E. Hardingham, H. Tschesche, and J.A. Hamilton. 1993. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem. J. 295:273-276.
31. Fosang, A.J., K. Last, V. Knäuper, G. Murphy, C.E. Hughes, and P.J. Neame. 1996. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380:17-20.
32. Sandy, J.D., P.J Neame, R.E. Boynton, and C.R. Flannery. 1991. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 266:8683-8685.
33. Ilic, M.Z., C.J. Handley, H.C. Robinson, and M.T. Mok. 1992. Mechanism of catabolism of aggrecan by articular cartilage. Archiv. Biochem. Biophys. 294:115-122.
34. Loulakis, P., A. Shrikhande, G. Davis, and C.A. Maniglia. 1992. N-Terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Biochem. J. 284:589-593.
35. Ropes, M.W., G.A. Bennet, S. Cobb, R. Jacox, and R.A. Jessar. 1959. Revision of diagnostic criteria for rheumatoid arthritis. Ann. Rheum. Dis. 18: 49-53.
36. Altman, R., E. Asch, D. Bloch, G. Bole, D. Borenstein, K. Brandt, W. Christy, T.D. Cooke, R. Greenwald, M. Hochberh, et al. 1986. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 29:1039-1049.
37. Willkens, R.F., F.C. Arnett, and T. Bitter. 1982. Reiter's syndrome: evaluation of preliminary criteria for definite disease. Bull. Rheum. Dis 32:31-34.
38. Altman, D.G. 1991. Practical Statistics for Medical Research. Chapman & Hall, London. 277-324.
39. Doege, K.J., M. Sasaki, T. Kimura, and Y. Yamada. 1991. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human specific repeats and additional alternatively spliced forms. J. Biol. Chem. 266:894-902.
40. Farndale, R.W., C.A. Sayers, and A.J. Barrett. 1982. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect. Tissue Res. 9:247-248.
41. Barry, F.P., L.C. Rosenberg, J.U. Gaw, T.J. Koob, and P.J. Neame. 1995. N- and O-linked keratan sulfate on the hyaluronan binding region of aggrecan from mature and immature bovine cartilage. J. Biol. Chem. 270:20516-20524.
42. Fairbanks, G., T.L. Steck, and D.F.H. Wallach. 1971. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry. 10:2606-2616.
43. Mehmet, H., P. Scudder, P.W. Tang, E.F. Hounsell, B. Caterson, and T. Feizi. 1986. The antigenic determinant recognized by three monoclonal antibodies to keratan sulfate involve sulfated hepta or larger oligosaccharides of the poly (N-acetyllactosamine) series. Eur. J. Biochem. 157:385-391.
44. Caterson, B., A. Calabro, P.J. Donohue, and M.R. Jahnke. 1986. Monoclonal antibodies against cartilage proteoglycan and link protein. In Articular Cartilage Biochemistry. K.E. Kuettner, R. Schleyerbach, and V.C. Hascall, editors. Raven Press, New York. 59-73.
45. Dudhia, J., C.M. Davidson, T.M. Wells, D.H. Vynios, T.E. Hardingham, and M.T. Bayliss. 1996. Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage. Biochem. J. 313:933-940.
46. Hutton, S., J. Hayward, R.A. Maciewicz, and M. Bayliss. 1996. Age-related and zonal distribution of aggrecanase activity in normal and osteoarthritic human articular cartilage. Trans. Orthop. Res. Soc. 21:150.
47. Heincgård, D., and I. Axelsson. 1977. Distribution of keratan sulfate in cartilage proteoglycans. J. Biol. Chem. 252:1971-1979.
48. Hanley, J.A., and A. Lippman-Hand. 1983. If nothing goes wrong is everything all right? Interpreting zero numerators. JAMA. 249:1743-1745.
49. Maniglia, C.A., P.P. Loulakis, A.V. Shrikhande, and G. Davis. 1991. IL-1 elevated PG degradation reveals NH2-terminal sequence homology. Trans. Orthop. Res. Soc. 16:193.
50. Plaas, A.H.K., and J.D. Sandy. 1993. A cartilage explant system for studies on aggrecan structure, biosynthesis and catabolism in discrete zones of the mammalian growth plate. Matrix. 13:135-147.
51. Bayne, E.K., S.A. Donatelli, I.I. Singer, J.R. Weidner, N.I. Hutchinson, L.A. Hoerrner, H.R. Williams, R.A. Mumford, L.S. Lohmander, and M.W. Lark. 1994. Detection of a metalloproteinase-generated aggrecan HABR fragment within human OA and RA cartilage. Trans. Orthop. Res. Soc. 19:308.
52. Fosang, A.J., K. Last, P.J. Neame, G. Murphy, V. Knäuper, H. Tschesche, C.E. Hughes, B. Caterson, and T.E. Hardingham. 1994. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem. J. 304:347-351.
53. Fosang, A.J., K. Last, P.J. Neame, T.E. Hardingham, G. Murphy, and J.A. Hamilton. 1993. Collagenase, plasmin and urokinase-type plasminogen activator cleave the aggrecan interglobular domain. Orthop. Trans. 17:848-849.
54. Mok, M.T., M.Z. Ilic, C.J. Handley, and H.C. Robinson. 1992. Cleavage of proteoglycan aggregate by leucocyte elastase. Arch. Biochem. Biophys. 292: 442-447.
55. Vilím, V., and A.J. Fosang. 1994. Proteoglycans isolated from dissociative extracts of differently-aged human articular cartilage: characterization of naturally-occuring hyaluronan-binding fragments of aggrecan. Biochem. J. 304: 887-894.
56. Singer, I.I., S. Scott, D.W. Kawka, E.K. Bayne, S.A. Donatelli, J.R Weidner, H.R. Williams, R.A. Mumford, M.W. Lark, J. McDonnell, et al. 1995. Aggrecanase and metalloproteinase-specific aggrecan neoepitopes are induced in the articular cartilage of mice with collagen II arthritis. Trans. Orthop. Res. Soc. 20:330.
57. Bayne, E.K., S.A. Donatelli, J. Sargeant, I.I. Singer, M.W. Lark, L.A. Hoerrner, J.R. Weidner, H.R. Williams, R.A. Mumford, and L.S. Lohmander. 1995. Aggrecan fragments terminating in the sequence N1TEGE373 are present within human OA and RA cartilage. Trans. Orthop. Res. Soc. 20:328.
58. Cawston, T.E., L. Weaver, R.J. Coughlan, M.V. Kyle, and B.L. Hazelman. 1989. Synovial fluids from infected joints contain active metalloproteinases and no inhibitory activity. Br. J. Rheumatol. 28:386-392.
59. Cawston, T., P. McLaughlan, R. Coughlan, V. Kyle, and B. Hazleman. 1990. Synovial fluids from infected joints contain metalloproteinase-tissue inhibitor of metalloproteinase (TIMP) complexes. Biochim. Biophys. Acta. 1033: 96-102.
60. Cole, A.A., and K.E. Kuettner. 1995. MMP-8 (neutrophil collagenase) mRNA and aggrecanase cleavage products are present in normal and osteoarthritic human articular cartilage. Acta Orthop. Scand. 66 (Suppl. 266):98-102.
61. Pratta, M.A., M.D. Tortorella, P. Gunyuzulu, G. Davis, H. George, and E.C. Arner. 1996. Co-induction of MMP-3 and MMP-8 synthesis in human chondrocytes in response to interleukin-1. Trans. Orthop. Res. Soc. 21:170.
62. Cole, A.A., S. Chubinskaya, B. Schumacher, K. Huch, G. Cs.-Szabó, J. Yao, K. Mikecz, K.A. Hasty, and K.E. Kuettner. 1996. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J. Biol. Chem. 271:11023-11026.
63. 374) is a primary event in proteolysis of the interglobular domain. J. Biol. Chem. 270:2550-2556.